A Study to Assess the Efficacy and Safety of WSD0922-FU in Patients With EGFRm+ Advanced Non-small Cell Lung Cancer

Clinical trial NCT06631989 · RECRUITING

Trial details

NCT number: NCT06631989
Sponsor: Wayshine Biopharm, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer

Start date: 2024-09-04
Primary completion: 2027-06-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.